Details for Patent: 8,802,142
✉ Email this page to a colleague
Which drugs does patent 8,802,142 protect, and when does it expire?
Patent 8,802,142 protects KEPPRA and is included in one NDA.
Protection for KEPPRA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-nine patent family members in twenty-five countries.
Summary for Patent: 8,802,142
| Title: | Pharmaceutical compositions comprising levetiracetam and process for their preparation |
| Abstract: | The present invention relates to a pharmaceutical composition comprising levetiracetam as active ingredient and 2.0 to 9.0% per weight of disintegrant, 0.0 to 3.0% per weight of gliding agent, 0.5 to 6.0% per weight of binder, and 0.0 to 1.0% per weight of lubricant, with respect to the total weight of the pharmaceutical composition, and to a process for its preparation. |
| Inventor(s): | Deleers; Michel (Linkebeek, BE), Hubert; Jean-Beno t (Haaltert, BE) |
| Assignee: | UCB Pharma, S.A. (Brussels, BE) |
| Application Number: | 11/910,167 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; Process; |
Drugs Protected by US Patent 8,802,142
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | KEPPRA | levetiracetam | TABLET;ORAL | 021035-004 | Jan 6, 2006 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Ucb Inc | KEPPRA | levetiracetam | TABLET;ORAL | 021035-001 | Nov 30, 1999 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Ucb Inc | KEPPRA | levetiracetam | TABLET;ORAL | 021035-002 | Nov 30, 1999 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Ucb Inc | KEPPRA | levetiracetam | TABLET;ORAL | 021035-003 | Nov 30, 1999 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,802,142
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 05016189 | Jul 26, 2005 | |
| 05016945 | Aug 4, 2005 | |
| PCT Information | |||
| PCT Filed | July 24, 2006 | PCT Application Number: | PCT/EP2006/007260 |
| PCT Publication Date: | February 01, 2007 | PCT Publication Number: | WO2007/012439 |
International Family Members for US Patent 8,802,142
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 054581 | ⤷ Try a Trial | |||
| Australia | 2006274263 | ⤷ Try a Trial | |||
| Brazil | PI0606121 | ⤷ Try a Trial | |||
| Canada | 2581831 | ⤷ Try a Trial | |||
| China | 101068534 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
